AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
AbbVie (NYSE: ABBV) has been a favorite for income investors since spinning off from Abbott Labs (NYSE: ABT) in 2013. For much of the past 13 years, the big drugmaker offered one of the more attractive dividend yields in the healthcare sector. However, AbbVie's dividend yield today hovers around 2.6% -- the lowest level since early 2018. For investors accustomed to collecting yields of 3.5% or more, this relatively smaller amount might not seem appealing. But there's a good case to be made that AbbVie is still a great pick for income investors anyway. Image source: Getty Images. Continue reading